Insulet | PODD - 股票



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 10.3B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


股票 更改 日
Abbott USD 6.99B 501M 2026-03
Align Technology USD 212.24M 2.7M 2026-06
AtriCure USD 83.92M 2.78M 2026-06
Baxter International USD 2.26B 57M 2026-06
Becton, Dickinson and Co. USD 3.32B 41M 2026-06
Boston Scientific USD 3.24B 118M 2026-06
Cardinal Health USD 17.3B 710M 2026-06
Cooper Companies USD 876.4M 30.4M 2025-12
Dexcom USD 726.4M 32.8M 2026-06
Edwards Lifesciences USD 1.13B 12.2M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Globus Medical USD 810.9M 38.3M 2026-06
ICU Medical USD 607.42M 1.83M 2026-06
Inogen USD 25.08M 762K 2025-09
Insulet USD 484.8M 22.3M 2026-06
Integra LifeSciences USD 492M 3.03M 2026-06
J&J USD 15.14B 561M 2026-06
Medtronic USD 5.95B 358M 2026-03
Merit Medical Systems USD 374.11M 21.73M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Solventum Corp USD 1.04B 49M 2026-06
Stryker USD 5.52B 102M 2026-06
Tandem Diabetes Care USD 135.11M 8.71M 2026-06
Teleflex USD 351.91M 28.95M 2026-06
West Pharmaceutical Services USD 447.4M 5.2M 2026-06
Zimmer Biomet Holdings USD 2.27B 23.5M 2026-06